Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

red yeast rice

What does the research say about red yeast rice?

3 health outcomes synthesised

Red yeast rice, a traditional Chinese fermented rice product, has been studied primarily for its cholesterol-lowering effects. Across 3 researched health outcomes, the strongest evidence exists for reducing total blood cholesterol, where 4 studies show large effects in adults with dyslipidemia at doses of 200–4800 mg daily. Research also indicates benefits for lowering LDL cholesterol and apolipoprotein B levels, though the evidence base is small and subject to publication bias.

Strongest evidence: The most robust research supports red yeast rice for reducing total blood cholesterol (moderate evidence strength). Across 4 studies, all reported beneficial effects, with 2 meta-analyses showing mean reductions of approximately 31–33 mg/dL — a large effect size. Doses ranged from 200–4800 mg daily, typically studied over 8–12 weeks in adults with dyslipidemia or hyperlipidemia.

Weaker evidence: For reducing LDL cholesterol and reducing apolipoprotein B levels, the evidence strength is low. All 4 studies on LDL and all 3 studies on apoB reported benefits, but the evidence bases are small, rely heavily on meta-analyses rather than original trials, and several studies did not isolate red yeast rice’s effect from other nutraceuticals. Effect sizes were moderate for both outcomes.

Effective dose patterns: Across outcomes, effective doses converged on 200–4800 mg/day of red yeast rice, or up to 10 mg/day of monacolin K. Shorter-term studies (median 8 weeks) were sufficient to observe effects, though the broad dose range and inconsistent reporting of monacolin content limit precision.

Population insights: All studies focused on adults with dyslipidemia, hyperlipidemia, or mild-to-moderate lipid elevations without known cardiovascular disease. No studies specifically examined elderly or deficient populations, so findings are limited to these clinical populations.

Notable caveats: The evidence is subject to publication bias — null results are less likely to be published. The evidence base is small (3–4 studies per outcome), and conclusions should be considered preliminary. Many studies did not specify the monacolin content or form of red yeast rice, which may affect reproducibility. Two of three studies on apoB were reviews/meta-analyses, and the sole original RCT had only 18 patients.

Frequently asked

  • What is red yeast rice good for according to research?
    Research shows red yeast rice may help reduce total blood cholesterol, LDL cholesterol, and apolipoprotein B levels in adults with dyslipidemia. The strongest evidence is for total cholesterol reduction, where 4 studies report large effects, with mean reductions of 31–33 mg/dL.
  • What dose of red yeast rice is typically used in studies?
    Studies have used doses ranging from 200 mg/day to 4800 mg/day of red yeast rice, or up to 10 mg/day of monacolin K. Effects are typically observed after 8–12 weeks of supplementation.
  • Who benefits most from red yeast rice?
    All studies focused on adults with dyslipidemia, hyperlipidemia, or mild-to-moderate lipid elevations without known cardiovascular disease. Findings may not apply to other populations, such as individuals with normal cholesterol or those with existing heart disease.
  • Are there caveats or limitations in the research on red yeast rice?
    Yes. The evidence base is small (3–4 studies per outcome), and conclusions should be considered preliminary. Publication bias is a concern — null results are less likely to be published. Many studies did not report the monacolin content or form of red yeast rice used, which may affect reproducibility.
  • Does red yeast rice help reduce LDL cholesterol?
    Evidence from 4 studies suggests it may, but the evidence strength is low. All 4 studies reported beneficial effects with moderate effect sizes, but three were reviews or meta-analyses rather than original trials, and one review did not isolate red yeast rice's effect from other nutraceuticals.
  • How quickly do effects on cholesterol occur in studies?
    The median study duration across outcomes was 56–70 days (8–10 weeks), suggesting effects are typically observed within 8 weeks. Few studies examined longer-term outcomes beyond 12 weeks.
  • Red Yeast Rice

    By NOW Foods

    4.7 (2K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $37.37
    In
    iHerb
    $34.29
    In
    Vitacost
    $32.09
    In
    Vitamin Shoppe
    $-
    Out
  • Red Yeast Rice

    By NOW Foods

    4.7 (2.6K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $34.34
    In
    iHerb
    $30.61
    In
    Vitacost
    $28.00
    In
    Vitamin Shoppe
    $34.99
    In
  • Red Yeast Rice

    By NOW Foods

    4.7 (2K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $18.80
    In
    iHerb
    $17.75
    In
    Vitacost
    $16.49
    In
    Vitamin Shoppe
    $-
    Out
  • Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $25.00
    In
    Vitacost
    $25.34
    In
    Vitamin Shoppe
    $-
    Out
  • Red Omega

    By NOW Foods

    4.8 (1.2K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $33.68
    In
    iHerb
    $34.29
    In
    Vitacost
    $32.09
    In
    Vitamin Shoppe
    $-
    Out
  • Red Yeast Rice

    By NOW Foods

    4.7 (2.6K reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $30.62
    In
    iHerb
    $15.91
    In
    Vitacost
    $14.69
    In
    Vitamin Shoppe
    $-
    Out
Back to top